Ludwig Institute

At the AACR annual meeting, researchers highlighted genomics- and proteomics-informed research aimed at establishing more effective, targeted immunotherapies.

The Epigenetics For Female Personalised Cancer Care (EpiFemCare) project recently published its findings in two papers in the journal Genome Medicine.

The funding will, in part, support efforts to expand the project's catalog of functional elements and understand their roles in different contexts.

The method was developed in the laboratory of Rickard Sandberg at the Ludwig Institute for Cancer Research in Stockholm and published by his group in 2013.

In several studies published this week, members of the Mouse ENCODE Consortium report on efforts to untangle regulatory networks in mouse cells -- analyses that uncovered features similar to, but distinct from, those described in humans.

NEW YORK (GenomeWeb Daily News) – Based on a global analysis of allelic expression in single cells, Ludwig Institute for Cancer Research investigators reported that which allele is expressed in a given cell is random.

NEW YORK (GenomeWeb News) – Glioblastoma tumors essentially hide mutant EGFR in response to therapies targeting those mutations, a new study appearing in Science reported today.

Direct-to-consumer genomics testing firm 23andMe has appointed Andy Page as its president, a newly created post. Page, who has served as a member of 23andMe's board of directors for the past year, will report to CEO and co-founder Anne Wojcicki.

The Ludwig Institute for Cancer Research has appointed David Lane to be its new scientific director, effective June 1. He succeeds Andrew Simpson, who was scientific director for five years, from 2007 to 2012.

Several high-profile research organizations, including the National Institutes of Health, have contributed a number of personalized medicine-focused biomarker- and diagnostics-related patents to a new intellectual property licensing "supermarket" called Librassay.

Pages

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.